Skip Navigation


European Heart Journal Advance Access originally published online on December 21, 2006
European Heart Journal 2007 28(2):269; doi:10.1093/eurheartj/ehl429
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/2/269    most recent
ehl429v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bäck, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bäck, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Gamma-glutamyltransferase, leukotrienes, and cardiovascular risk

Magnus Bäck

Department of Cardiology and Center for Molecular Medicine
Karolinska University Hospital L8:03
171 76 Stockholm
Sweden
Tel: +46 8 51770000
Fax: +46 8 313147
E-mail address: magnus.back@cmm.ki.se
Member of the ESC Working Group on Pathogenesis of Atherosclerosis (WG 23)

The first 10% of the full text of this article appears below.

It is with great interest that I read the article ‘Serum gamma-glutamyltransferase predicts myocardial infarction and fatal coronary heart disease . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?